Pricing Log in Create free account
Friday 6 November 2026 Export LFST’s income statement to Excel — free account

LifeStance Health Group, Inc.

LFST Healthcare Medical Care Facilities

LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.

Revenue
+25.3%
EPS
+2,042.9%
Free cash flow
+31.6%
Total debt
−5.15%

Quarter to September 2026, against a year earlier

13.44 0.77 −5.42%
Market cap
$5.1B
P/E
70.7×
Fwd P/E
81.1×
Dividend yield
—
F-score
8/9
Altman Z
2.65
Beneish M
−2.96
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Sold, $m 846.86
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell 4 — — 2 2 5 1 — 6 2 — —
Insider Ownership 31.97%

Capital & Financial Ratios $m

Size
Market Cap 5,130.00
Revenue ttm 1,676.89
Net income ttm 71.91
Free cash flow ttm 179.27
Net debt Q 36.71
Valuation
P/E 70.66 (above 35: high)
Forward P/E 81.10 (above 35: high)
Price / sales 3.06
Forward P/S Powerpack
Price / FCF 28.58
Price / book 3.43
Financial health
Current ratio Q 1.44
Debt / equity Q 0.17 (at or below 0.5: strong)
Interest coverage Q 13.28
Growth
Revenue growth Q +25.30% (above 0%: growing)
Operating income growth Q +346.38% (above 0%: growing)
EPS, this year +777.00% (at or above 15%: strong)
EPS, next year A +30.94% (at or above 15%: strong)
Revenue, next year A +19.99% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A +181.03% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 3.1×, against a ten-year median of 2.5×; over the ten years it ranged from 1.2× in 2025 to 16.4× in 2021.
P/S against its own 10 years 69.46%
10-year low 10-year high
P/B against its own 10 years 96.54%
10-year low 10-year high
EV/Sales against its own 10 years 67.18%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 79 155 249 219
Receivables 125 132 96 121
Inventory — — — —
Other — — — —
226 313 416 377
2023 2024 2025 Q'26
Payables 7 7 6 6
ST’ Debt — — — —
Other 12 8 15 21
203 229 252 261

Compound Annual Growth %

10y 5y 3y
Sales — 30.44% 18.33%
Cash Flow — 0.00% 40.42%
Earnings — 0.00% 0.00%
Book Value — 8.80% 0.05%

Earnings Trends EPS, adjusted, against the consensus

Q2 FY26 Estimate 0.03 Actual 0.06

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q3 FY25 −0.01 0.00 Beat by 0.01
Q4 FY25 0.00 0.03 Beat by 0.03
Q1 FY26 0.01 0.04 Beat by 0.03
Q2 FY26 0.03 0.06 Beat by 0.03
Q3 FY26 0.03 — Reports 5 November 2026

EPS $

Mar Jun Sep Dec Year
’26 0.04 0.06 0.06 — —
’25 0.00 (0.01) 0.00 0.03 0.02
’24 (0.06) (0.06) (0.02) (0.02) (0.15)
’23 (0.09) (0.13) (0.17) (0.12) (0.51)
’22 (0.18) (0.19) (0.11) (0.13) (0.61)
’21 (0.03) (0.22) (0.35) (0.32) (1.05)
’20 — (0.11) (0.01) (0.01) (0.04)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 403 435 456 — —
’25 333 345 364 382 1,424
’24 300 312 313 325 1,251
’23 253 260 263 281 1,056
’22 203 210 218 229 860
’21 143 161 174 190 668
’20 73 84 102 118 377
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 33 100 37 — —
’25 (3) 64 27 58 146
’24 (22) 44 23 62 107
’23 (8) 0 (25) 17 (17)
’22 3 8 6 36 53
’21 10 (17) (14) 31 9
’20 2 (26) 11 (9) (9)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 22 88 22 — —
’25 (10) 57 17 47 110
’24 (27) 39 18 56 86
’23 (16) (12) (35) 5 (57)
’22 (25) (18) (9) 26 (26)
’21 (1) (38) (38) (8) (85)
’20 (6) (36) 2 (7) (47)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.5
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — 213 377 668 860 1,056 1,251 1,424 1,677 +37.3% 1,709 1,956 2,253 +16.5%
Gross margin, % — — — 29.36 31.59 30.19 27.57 28.62 32.17 32.37 0.00 +3.0 pt
EBT — — — 8 (44) (333) (233) (207) (58) 12 90 +7.8%
EBT margin, % — — — 3.71 (11.77) (49.90) (27.08) (19.57) (4.61) 0.87 5.36 (2.8) pt
Net income — 0 — 6 (38) (307) (216) (186) (57) 10 72 n/m
Per share, $
Per share, $ Revenue — — — 0.57 1.25 2.04 2.42 2.87 3.30 3.69 4.40 +36.6%
Earnings — — — (0.16) (0.04) (1.05) (0.61) (0.51) (0.15) 0.03 0.19 n/m
Cash flow — — — 0.05 (0.03) 0.03 0.15 (0.05) 0.28 0.38 0.60 +42.3%
Capex — — — (0.04) (0.13) (0.29) (0.22) (0.11) (0.06) (0.09) (0.13) +16.1%
Free cash flow — — — 0.01 (0.15) (0.26) (0.07) (0.16) 0.23 0.29 0.47 +84.2%
Book value — — — (0.45) 3.30 4.72 4.27 3.89 3.81 3.94 3.91 n/m
Shares, m — — — 374 302 328 355 367 379 386 385 +0.5%
Valuation, ×
Valuation, × P/E — — — 0.00 0.00 0.00 0.00 0.00 0.00 283.87 70.66 40.6
P/S — — — 14.96 14.96 4.67 1.92 2.75 2.23 1.91 3.06 6.2
P/B — — — 7.01 7.01 2.02 1.09 2.03 1.93 1.79 3.43 3.3
EV/Sales — — — 15.74 15.74 4.69 2.06 2.94 2.33 1.92 3.08 6.5
EV/FCF — — — (166.98) (166.98) (36.76) (66.82) (54.08) 34.07 24.86 28.78 (61.8)
Cash, $m
Cash, $m Operating cash flow — — — 17 (9) 9 53 (17) 107 146 228 +43.1%
Capex — — — (14) (38) (94) (79) (41) (22) (36) (48) +16.7%
Free cash flow — — — 3 (47) (85) (26) (57) 86 110 179 +85.1%
Balance, $m
Balance, $m Working capital — — — (28) 0 150 57 23 84 164 116 n/m
Net debt — — — 76 344 9 116 201 125 17 37 (21.8%)
Shareholders’ equity — — — (166) 998 1,545 1,519 1,429 1,446 1,521 1,492 n/m
Returns, %
Returns, % ROA — — — (41.96) (33.65) (19.67) (10.51) (8.70) (2.72) 0.45 3.32 +42.4 pt
ROIC — — — 0.00 0.72 (11.51) (8.03) (7.25) (1.26) 0.98 4.25 +1.0 pt
ROE — — — (14.16) (74.88) (27.05) (14.07) (12.64) (4.00) 0.65 4.82 +14.8 pt
People
People Employees — — — — 2,674 4,790 7,830 9,325 10,218 10,961 — +32.6%
Revenue/emp, $m — — — 0.00 0.14 0.14 0.11 0.11 0.12 0.13 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026

LifeStance Health Group, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
PACS PACS Group, Inc. $8.0B 28.6× 21.8× +11.45% (above 0%: growing) +16.36% (above 0%: growing) −4.31% (below 0%: shrinking) 17.23% 6.65% Compare
CHE Chemed Corporation $7.0B 25.5× 24.0× +10.57% (above 0%: growing) +23.09% (above 0%: growing) −45.25% (below 0%: shrinking) 33.72% 13.96% Compare
CON Concentra Group Holdings Parent, Inc. $5.4B 24.9× 25.2× +8.61% (above 0%: growing) +36.84% (above 0%: growing) −19.76% (below 0%: shrinking) 31.42% 18.52% Compare
LFST LifeStance Health Group, Inc. $5.1B 70.7× 81.1× +25.30% (above 0%: growing) +2,042.86% (above 0%: growing) +31.57% (above 0%: growing) 0.00% 7.26%
OPCH Option Care Health, Inc. $4.7B 22.6× 21.2× +4.08% (above 0%: growing) +19.81% (above 0%: growing) −17.04% (below 0%: shrinking) 19.08% 5.97% Compare
NHC National HealthCare Corporation $3.3B 28.2× 8.4× +6.61% (above 0%: growing) −65.61% (below 0%: shrinking) +75.52% (above 0%: growing) 100.00% 0.00% Compare
ACHC Acadia Healthcare Company, Inc. $3.2B — (loss-making) 34.4× +5.14% (above 0%: growing) −5.00% (below 0%: shrinking) +196.54% (above 0%: growing) 100.00% 0.00% Compare
SGRY Surgery Partners, Inc. $3.0B — (loss-making) — (loss-making) +2.75% (above 0%: growing) n/m −60.63% (below 0%: shrinking) 22.41% 12.78% Compare
AVAH Aveanna Healthcare Holdings Inc. $3.0B 10.5× 18.3× +13.73% (above 0%: growing) +46.15% (above 0%: growing) +57.89% (above 0%: growing) 32.59% 11.93% Compare
Median of peers $4.0B 25.2× 21.8× +7.61% +19.81% −10.67% 32.01% 9.29%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 22 April 2026

Ownership

Directors and executive officers, together 3.50%
Parties to the Stockholders Agreement 43.60%
TPG VIII Lynnwood Holdings Aggregation, L.P. 36.10%
FMR, LLC 12.00%
Summit Partners and affiliates 7.50%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

LifeStance Health Group, Inc. (LFST) Latest News

6 Nov

Impact 3 · · MarketBeat

5 Nov

Impact 4 · · GlobeNewswire
Impact 3 · · GuruFocus.com
Impact 3 · · The Motley Fool transcript
Impact 3 · · Associated Press
Impact 3 · · StockStory

29 Oct

Impact 4 · · PR Newswire
Impact 3 · · TIKR

26 Oct

Impact 3 · · Simply Wall St.

20 Oct

Impact 3 · · StockStory

30 Sep

Impact 3 · · PR Newswire

28 Sep

Impact 3 · · Simply Wall St.

21 Sep

Impact 3 · · StockStory

16 Sep

Impact 4 ·

14 Aug

Impact 3 ·

12 Aug

Impact 4 ·

11 Aug

Impact 3 ·

9 Aug

Impact 4 ·

6 Aug

Impact 4 · · The Motley Fool transcript
Impact 4 · transcript
Impact 4 · · Moby transcript
Impact 4 ·
Impact 4 ·
Impact 3 · · MarketBeat transcript

3 Aug

Impact 3 ·

18 Jun

Impact 3 ·

17 May

Impact 3 · · StockStory

13 May

Impact 3 · · Zacks
Impact 3 · · Zacks

11 May

Impact 4 · · StockStory

LFST metrics, ten years each

stockrow.com/LFST · Data as of Nov 5, 2026 · For information only; not investment advice. · © 2026 stockrow.com